The effect of raloxifene on cognitive function in postmenopausal women: A randomized clinical trial

Connecticut Medicine

Volumn 68, Issue 6, 2004, Pages 355-358

  Haskell, Sally G ^a,c   Richardson, Emily D ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RALOXIFENE;

ADULT; AGED; ARTICLE; BECK ANXIETY SCALE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGIT CANCELLATION TEST; FEMALE; HUMAN; INTELLIGENCE TEST; POSTMENOPAUSE; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SHORT FORM 36 SCALE; TREATMENT OUTCOME; WECHSLER MEMORY SCALE; WELLBEING;

AGED; COGNITION; FEMALE; HEALTH SURVEYS; HUMANS; INTERVIEWS; MIDDLE AGED; POSTMENOPAUSE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 2942718839     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. McEwen BS: The molecular and neuroanatomical basis for estrogen effects in the CNS. J Clin Endocrinol Metab 1999; 84: 1790-7.
2. LeBlanc ES,Janowsky J,Chan BK, Nelson HD: Hormone replacement therapy and cognition: Systematic review and metaanalysis. JAMA 2001; 285:1489-99.
3. Rapp SR, Espeland MA, Shumaker SA, et al: The effect of estrogen plus progestin on global cognitive function in postmenopausal women. The women's health initiative memory study: A randomized controlled trial. JAMA 2003; 289(20):2663-72.
4. Nickelsen T, Lufkin DG, Riggs BL, et al: Raloxifene hydrochloride, a selective estrogen receptor modulator: Safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology 1999; 24:115-28.
5. Yaffee K, Krueger K, Sarkar S, et al: Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med 2001; 44:1207-13.
6. Wu X, Glinn MA, Ostrowski NL, et al: Raloxifene and estradiol benzolate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats. Brain Res 1999; 847:98-104.
7. Nilsen J, Mor G, Naftolin F: Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells. Menopause 1998; 5: 211-16.
8. Beck AT, Steer RA, Brown GK: Beck Depression Inventory - II. San Antonio, TX: The Psychological Corporation, 1996.
9. Beck AT: Beck Anxiety Inventory. San Antonio, TX: The Psychological Corporation, 1993.
10. Hays RD, Sherbourne CD, Mazel RM: The RAND 36-item Health Survey 1.0. Health Economics 1993; 2:217-27.
11. Wechsler D: The Wechsler Adult Intelligence Scale-Third Edition. San Antonio, TX: The Psychological Corporation, 1997.
12. Kelland DZ, Lewis RF: Evaluation of the reliability and validity of the Repeatable Cognitive-Perceptual-Motor Battery. Clin Neuropsychol 1994; 8:295-308.
13. Wechsler D: The Wechsler Memory Scale-Third Edition. San Antonio, TX: The Psychological Corporation, 1997.
14. SAS Institute, Inc. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute, 1999.
15. Phillips SM, Sherwin BB: Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17:485-92.
16. Rauramo L, Lagerspetz K, Engblom P: The effect of castration and per oral estrogen therapy on some psychological functions. Fron Horm Res 1975; 3:94-104
17. Vanhulle G, Demol R: A double-blind study into the influence of estriol on a number of psychological tests in post-menopausal women. In: van Keep PA, Greenblatt RB, Albeaux-Feurnet MM, eds. Consensus on Menopausal Research London: MTP Press, 1976; 94-99.
18. Ditkoff EC, Crary WG, Cristo M, Lobo RA: Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecology 1991; 78:991-5.
19. Neele SFJ, Rombouts SARB, Bierlaagh MA, et al: Raloxifene affects brain activation patterns in postmenopausal women during visual encoding. J Clin Endocrin Metabol 2001; 86:1422-5.